PARIS (Agefi-Dow Jones)–Sanofi’s board of directors unanimously appointed Frédéric Oudéa as censor on Friday, with effect from that date, the pharmaceutical group announced on Monday.
Furthermore, the appointment of Frédéric Oudéa as a director of Sanofi will be submitted for approval to the group’s next general meeting.
Following this general meeting, “it will be proposed to the board of directors of Sanofi the appointment of Frédéric Oudéa as non-executive chairman of this board, replacing Serge Weinberg whose term of office will have expired”, indicated the pharmaceutical group in a press release.
Frédéric Oudéa has announced that he will step down as Chief Executive Officer and Director of Societe Generale in May 2023.
-Dimitri Delmond, Agefi-Dow Jones; +33 (0)1 41 27 47 31; [email protected] ed: VLV
Agefi-Dow Jones The financial newswire
Dow Jones Newswires
September 05, 2022 01:19 ET (05:19 GMT)